Hepatobiliary Surgery and Nutrition

Article	Citations
Reply to: The letter to the editor “More details are needed about the use of multicenter propensity score matching analysis” by Feng et al.	141
Review of practice informing data and current state of NCCN consensus guidelines in hepatobiliary cancers	106
Neoadjuvant therapy for resectable pancreatic cancers	75
Preoperative assessment of liver function and perioperative management of posthepatectomy liver failure	67
Does a patient who needs portal vein embolization (PVE) to proceed to major hepatectomy (MH) have the same hepatic functional reserve than a patient with no preoperative PVE?	49
Can we talk about “futile surgery” for the upfront treatment of the perihilar cholangiocarcinoma?	48
Futibatinib: new targeted therapy in intrahepatic cholangiocarcinoma	42
Managing portal hypertension in patients with liver cirrhosis and hepatocellular carcinoma: non-invasive diagnosis and systemic treatment considerations	36
Short postoperative hospital stay after pancreaticoduodenectomy: what is real minimally invasive surgery?	34
Acute coil migration in upper gastrointestinal bleeding	33
Heterogeneity in the risk of incident liver cirrhosis driven by PNPLA3 genotype and diabetes among different populations	28
Technical performance, surgical workload and patient outcomes of robotic and laparoscopic surgery for pediatric choledochal cyst: a multicenter retrospective cohort and propensity score-matched study	27
Assessment of long-term graft function following total pancreatectomy and autologous islet transplantation: the Leicester experience	27
Nonalcoholic steatohepatitis critically rewires the ischemia/reperfusion-induced dysregulation of cardiolipins and sphingolipids in mice	26
The application of real-time indocyanine green fluorescence cholangiography in laparoscopic living donor left lateral sectionectomy	24
Prospective evaluation of 18F-FDG positron emission tomography in the preoperative staging of patients with hepatic colorectal metastases	23
Loco-regional treatments of unresectable hepatocellular carcinoma: safety first	21
Surgical treatment of colorectal cancer liver metastases: individualized comprehensive treatment makes a difference	21
Enhanced recovery for liver transplantation: recommendations from the 2022 International Liver Transplantation Society Consensus Conference: towards better clinical care in transplant hepatology	21
Innovations in liver organoids: the role of 3D bioprinting in creating functional organoids	20
Comment on “Perihilar cholangiocarcinoma—novel benchmark values for surgical and oncological outcomes from 24 expert centers”	20
A 7-year-old girl with giant congenital biliary dilatation	20
Reply to the commentary on “The efficiency of pathological response after preoperative transcatheter arterial chemoembolization for microvascular invasion and early tumor recurrence in hepatocellular	20
Comment on: “Liver transplantation for iatrogenic bile duct injury during cholecystectomy: a French retrospective multicenter study”	17
Performance of major liver resection for gallbladder cancer—a western retrospective single center cohort study	16

The Society for Immunotherapy of Cancer clinical practice guideline on immunotherapy for hepatocellular carcinoma	16
Liver transplantation for hepatocellular carcinoma arising in non- cirrhotic liver: a national-wide retrospective cohort study with propensity score matching analysis in China	16
Evolocumab induced short-term biliary stent blockage and acute cholangitis in a jaundice patient with pancreatic carcinoma: a rare complication of PCSK9 inhibitor	15
Construction and application of multicellular tumor microenvironment models based on three-dimensional bioprinting technology	15
Addressing the malnutrition gap requires high-quality research, recognition of intervention complexity, and equitable implementation strategies	15
Robotic hepatectomy: challenge and progression	15
Expert consensus on difficult airway assessment	14
Enhancing diagnostic strategies for biliary strictures: an evolving landscape	14
Extracellular vesicles small RNA clusters: hit the nail on the head of liver cancer detection	14
Guidelines for the management of pancreatic cystic lesions: many options, too few solutions?	14
Propensity score matching study of 325 patients with spontaneous rupture of hepatocellular carcinoma	13
Novel biomarkers for hepatocellular carcinoma detection and treatment	13
A novel radiomics signature based on T2-weighted imaging accurately predicts hepatic inflammation in individuals with biopsy-proven nonalcoholic fatty liver disease: a derivation and independent valid	13
Dietitians’ role in obesity care: insights from the Academy of Nutrition and Dietetics	13
Body fat distribution: a crucial target for intervention in nonalcoholic fatty liver disease and fibrosis	12
Editorial comment on: development and external validation of a model to predict overall survival in patients with resected gallbladder cancer	12
Perioperative management of patients with liver cancer complicated with sarcopenia	12
“One-day, one-stay, and one-step” lessons from the Danish guidelines for the treatment of gallstone disease	12
How to improve the care of decompensated cirrhosis: the intervention model for chronic disease management	11
Optimizing strategies to reduce alcohol consumption and relapses, improving abstinence in liver transplant recipients	11
Does preoperative routine statin use reduce post-hepatectomy liver failure?—an international multicentre retrospective cohort study on 2,342 patients	11
Safety analysis of COVID-19 vaccines in liver transplant recipients: a two-center study	11
Resection and yttrium-90 radioembolization as sequential downstaging to living donor liver transplantation for large, multifocal hepatocellular carcinoma with lobar portal vein tumor thrombosis	10
The 11th revision of the International Statistical Classification of Disease and Related Health Problems and Cholangiocarcinoma	10
Laparoscopic partial splenectomy in the treatment of splenic ectopic pregnancy	10
Understanding drug-induced liver injury from the perspective of traditional Chinese medicine theory—Huohou theory of traditional Chinese medicine	9
Practice guidance documents for the diagnosis and management of non-alcoholic fatty liver disease—recent updates and open questions	9
Impact of donor-recipient sex-matching patterns on liver transplantation outcomes: a cohort study based on United Network of Organ Sharing data	9
Association of a novel glycemic control index, time in range, with infectious complications after pancreatectomy	9
Construction of an intrahepatic portosystemic shunt using the magnetic compression technique: preliminary experiments in a canine model	8
Rules: abide or abandon?	8
Liver resection versus liver transplantation for hepatocellular carcinoma within Milan criteria: a meta-analysis of 18,421 patients	8
Thermal ablation in the curative treatment of colorectal liver metastasis: new standard of care?—lessons learned from the COLLISION trial	8
Highlights of constructing liver-relevant in vitro models with 3D bioprinting	8
Robotic-assisted hepatopancreatoduodenectomy and resection of pancreatic tail for one multiple endocrine neoplasia type 1 secreting multiple hormones	8
Trimming the fat myth: adipose tissue’s role in liver regeneration	8
Combination therapies for advanced hepatocellular carcinoma: a beacon of light or a castle in the air	8
Sengstaken-Blakemore tubes: a rescue system during liver transplantation	8
Targeted therapies in cholangiocarcinoma: light at the end of the tunnel?	8
Spontaneous regression of solid-pseudopapillary neoplasms with hepatic metastases	8
Minimally invasive hepatectomy is here to stay, but more evidence is needed	7
ALPPS versus portal vein embolization for hepatitis B virus-associated hepatocellular carcinoma: a delicate balance between volume and morbidity	7
Difficulties and opportunities of hospice care—the role of doctors	7
Metabolic (dysfunction) associated fatty liver disease: more evidence and a bright future	7
De-escalating local therapies without compromising outcomes: lessons from the COLLISION trial	7
Liver transplantation for perihilar cholangiocarcinoma is not a provocative idea	7
Prediction of postoperative early recurrence and response to adjuvant transcatheter arterial chemoembolization in hepatocellular carcinoma with microvascular invasion after hepatectomy: a multicenter	7
Development of scoring models to predict early pancreatic cancer risk in new-onset diabetes mellitus patients	7
Evolution of systemic therapy for advanced-stage hepatocellular carcinoma	7
Confounders in developing a machine learning model for colorectal liver metastasis post-hepatectomy prognostications	7

“Winning” with laparoscopic liver resection for colorectal cancer liver metastases (CRLM)	7
Metabolic dysfunction-associated fatty liver disease and hepatocellular carcinoma: present and future	7
Couinaud’s corrosion casts of the liver	7
De-escalating surgical treatment in low stage gallbladder cancer	6
Alcohol-related liver disease	6
Primary sclerosing cholangitis and cholangiocarcinoma: the 2023 practice guidance and future perspectives	6
Risk predictors of post-hepatectomy liver failure: unraveling complexities and navigating challenges in clinical application	6
ESMO 2023 pancreatic cancer guidelines signal stepwise progress	6
Ethical issues in innovative clinical research	6
Feasibility and outcomes of robotic partial pancreatoduodenectomy	6
Screening for pancreatic cancer in individuals with genetic susceptibility	6
Novel preoperative strategies to improve hepatocellular carcinoma resectability	6
Comparative effectiveness of medical treatment vs. metabolic surgery for histologically proven non-alcoholic steatohepatitis and fibrosis: a matched network meta-analysis	6
A systematic review of methodology in nutritional trials in patients undergoing pancreatoduodenectomy	6
How to deliver palliative care for patients with management in decompensated cirrhosis	6
Surgical resection for pancreatic ductal adenocarcinoma with liver metastasis: is this the beginning of a new era?	6
To drain or not to drain after distal pancreatectomy: reflexions on the PANDORINA trial	6
Serum metabolic effects of corn oligopeptides with 7-day supplementation on early post-surgery primary liver cancer patients: a double-blind randomized controlled trial	6
Getting persuasive about the non-invasive: assessing liver fibrosis in practice—without a biopsy	6
Adjuvant atezolizumab-bevacizumab after curative therapy for hepatocellular carcinoma	6
Advancements and challenges in robotic donor hepatectomy: current evidence and unresolved questions	6
Risk factors for non-alcoholic fatty liver disease delineate the battlegrounds in optimizing disease prevention	6
Laparoscopic duodenum-preserving pancreatic head resection guided by the two-stage indocyanine green fluorescence imaging	6
Algorithm-based care for early recognition and management of complications after pancreatic resection: toward standardization of postoperative care	6
The role of FGFR inhibitors in the treatment of intrahepatic cholangiocarcinoma—unveiling the future challenges in drug therapy	5
The lymphatic vessels of the liver observed by Frederik Ruysch	5
Surgical treatment for neuroendocrine liver metastasis: moving ahead in controversy	5
Liver transplantation for non-resectable colorectal metastases—an evolving paradigm in transplant oncology	5
EREG-secreting THBS1+ tissue monocytes are recruited by C5a to promote rapid liver regeneration in patients and mice during the ALPPS procedure	5
How will the latest modifications to the CG189 NICE guidelines for obesity management likely impact clinical care?	5
Can liver stiffness measurement accurately predict disease progression and clinical outcome in patients with metabolic dysfunction-associated steatotic liver disease and bridging fibrosis or cirrhosis	5
Rethinking portal hypertension in hepatocellular carcinoma resection: a gradient of risk beyond black and white	5
A new TNM T3 subclassification with corresponding prognostic stage grouping for gallbladder cancer: a multicenter retrospective study	5
Necessity of integrating statistical inference and clinical practice in developing clinical models: bias introduced by neoadjuvant chemotherapy	5
Non-invasive strategies to predict post-hepatectomy liver failure	5
Utilization of hepatitis B virus-positive allografts in liver transplantation: a new arrow to the bowstring for expanding the donor pool?	5
Comparative analysis of analgesic efficacy and functional recovery in open pancreaticoduodenectomy: a randomized controlled trial of local anesthetic wound infiltration, transversus abdominis plane bl	5
In situ liver resection under venovenous bypass (LR-VVB) or venoarterial bypass (LR-VAB) adjunct to total vascular exclusion (TVE) as extreme liver surgery	5
Molecular profiling and patient selection for the multimodal approaches for patients with resectable colorectal liver metastases	5
Decision-making in high-risk leakage duodenopancreatectomy: pancreatic anastomosis or total pancreatectomy?	5
Advanced pancreatic neuroendocrine neoplasia (pNEN): complex diseases with therapeutic challenges	5
Validation of the European Association for the Study of the Liver algorithm for the noninvasive diagnosis of advanced fibrosis in metabolic-dysfunction associated steatotic liver disease	5
Nutritional management guidelines for pancreatitis—a commentary	5
Early bifurcation of hepatic artery in right-sided living-donor hepatectomy at Asan Medical Center: rarely a critical issue	5
Surgical resection for hepatocellular carcinoma in cirrhotic patients with clinically significant portal hypertension: a multidisciplinary team decision	5
The Hong Kong consensus recommendations on the diagnosis and management of pancreatic cystic lesions	5
Can artificial intelligence deliver on the promise of precision medicine?	5
Endothelial glycocalyx damage marker syndecan-1 during hypothermic oxygenated machine perfusion of donor grafts facilitates prediction of early allograft dysfunction after liver transplantation	5
Impact of preoperative chemotherapy on surgical results in 139 patients with locally advanced pancreatic cancer	4
Atezolizumab plus bevacizumab for patients with Child-Pugh-B in hepatocellular carcinoma	4
Sex and age differences in the association between obesity and long-term changes with the risk of incident type 2 diabetes mellitus: the Rural Deqing Cohort Study	4
Exocrine pancreatic insufficiency: more compromise than precision	4
The difficulty of medical decision-making: should patients be involved?	4
Hepatic “pregnancy”: hepatocellular carcinoma with extensive extrahepatic growth	4
Living donor liver transplantation for Barcelona clinic liver cancer (BCLC) intermediate-stage hepatocellular carcinoma	4
Biliary sphincterotomy for sphincter of Oddi disorder: is sphincterotomy cutting it?	4
Intestinal autotransplantation: the next level of complexity in locally advanced pancreatic cancer	4
Importance of an appropriate number of examined lymph nodes in patients with pancreatic cancer—the more the better?	4
Lean individuals with nonalcoholic fatty liver disease, the chicken or the egg?	4
Insights on liver-directed surgical innovations, targeted therapies, and immunotherapy for biliary tract cancer: navigating the new European Society for Medical Oncology (ESMO) Clinical Practice Guide	4
Predictive model for very early recurrence of patients with perihilar cholangiocarcinoma: a machine learning approach	4
Portal hypertensive biliopathy secondary to Abernethy malformation mimicking a hepatic hilum mass	4
The impact of associating liver partition and portal vein ligation for staged hepatectomy (ALPPS) on liver tumors with unusual indications	4
Improving patient stratification and selection for curative-intent treatment in localized pancreatic cancer	4
Short- and long-term outcomes and cost-effectiveness of robotic-assisted versus laparoscopic liver resection for Barcelona Clinic Liver Cancer (BCLC) 0/A hepatocellular carcinoma: a multicenter propen	4
Beyond chemotherapy in biliary tract cancer: a closer look at the updated long-term follow-up data of the TOPAZ-1 trial	4
The global burden of fatty liver disease: the major impact of China	3
Advances and controversies in the management of acute cholecystitis in high-risk, critically ill, and unfit-for-surgery patients: the Italian Society of Emergency Surgery and Trauma guidelines	3
Surgical treatment strategies for multifocal hepatocellular carcinomas	3
New developments in ablation therapy for hepatocellular carcinoma: combination with systemic therapy and radiotherapy	3
Novel biomarkers and the future of targeted therapies in cholangiocarcinoma: a narrative review	3
A machine learning model for colorectal liver metastasis post-hepatectomy prognostications: several strategies for the model evaluation	3
Nonalcoholic fatty liver disease in early life and all-cause and cause-specific mortality	3
Assessment of morbidity and mortality after liver transplantation for primary sclerosing cholangitis	3
Optimizing venous outflow reconstruction for V5 & V8 in right-lobe living-donor liver transplantation: “half-circumferential anastomosis” using autologous vein grafts	3
Robotic pancreaticoduodenectomy after the learning curve—a new hope	3
Hepatic metastases in ovarian cancer	3
Neoadjuvant radiotherapy for resectable hepatocellular carcinoma with portal vein tumor thrombus: a systematic review	3
Is immunotherapy-related liver injury more common in patients with hepatocellular carcinoma than in other advanced solid tumors?	3
High risk of thrombosis recurrence in people with idiopathic or only locally caused non-cirrhotic splanchnic vein thrombosis: it is time for guidelines’ revision	3

The vascular endothelial growth factor system—a new player in the pathogenesis and development of metabolic dysfunction- associated steatotic liver disease	3
Specific metabolic impairments indicate loss of sustained liver improvements in metabolic dysfunction-associated steatotic liver disease treatment	3
The role of B cells in metabolic (dysfunction)-associated fatty liver disease	3
Is liver resection necessary for T2 gallbladder cancer?	3
Impact of adjuvant therapy on survival outcomes in resected gallbladder cancer: a systematic review and meta-analysis	3
Surgical techniques and tumor dissemination: a critical review of the CETUPANC trial on the superior mesenteric artery vs. no-touch approaches	3
Liver venous deprivation (LVD) before extended hepatectomy: a French multicentric retrospective cohort	3
Obesity and its influence on liver dysfunction, morbidity and mortality after liver resection	3
Ascites and complications: getting to the root of the trouble	3
UDP-glucuronosyltransferases mediate coffee-associated reduction of liver fibrosis in bile duct ligated humanized transgenic UGT1A mice	3
Advanced nonmetastatic hepatocellular carcinoma: curative surgery may be an option	3
Alternatives to left lateral segment for pediatric liver transplantation, or required surgeon toolkit?	3
Quest for an accurate and reproducible prognostic biomarker of severe acute pancreatitis: have we finally found it?	3
Assessing the financial and equity implications of the 2020 liver allocation policy change	3
Pancreatic cancer screening in high-risk individuals with genetic susceptibility	3
Choledochoscopic photodynamic therapy combined with biliary stent implantation for the treatment of unresectable hilar cholangiocarcinoma	3
A journey of a thousand miles begins with one small step	3
Modern surgical approach to hepatocellular carcinoma	3
Standardization is needed in reporting risk and outcomes of machine perfusion in liver transplantation	3
An intriguing case of macrolides-induced pancreatic injury mimicking pancreatic carcinoma	3
Guidelines towards comprehensive care in acute pancreatitis	3
Hepatoid adenocarcinoma of the rectal	2
Liver resection in obesity patients	2
Stereotactic body radiation therapy and radiofrequency ablation in patients with hepatocellular carcinoma: not a rival but a partner for the cure	2
Alternatives to left lateral sector in paediatric liver transplantation—a systematic review on monosegmental and reduced grafts	2
The promise of precision medicine: how biomarkers are shaping the future of cholangiocarcinoma treatment	2
Application of liver transplant techniques in complex liver surgery: modified techniques and preliminary results of complex liver resection using in-situ hypothermic portal perfusion without venovenou	2
Hepatocellular carcinoma in non-alcoholic fatty liver disease from a clinical and public health perspective	2
ALPPS and the endless pursuit of hepatic resectability	2
Long- and short-term outcomes for resectable gallbladder carcinoma patients treated with curative-intent laparoscopic versus open resection: a multicenter propensity score-matched comparative study	2
The presence of NAFLD in nonobese subjects increased the risk of metabolic abnormalities than obese subjects without NAFLD: a population-based cross-sectional study	2
Advances in minimally invasive liver surgery: comparing robotic and laparoscopic approaches	2
Rare case of leiomyomatosis peritonealis disseminata with hepatic involvement	2
Liver anatomy by Francis Glisson	2
Genomic alterations in hepatocellular carcinoma and their clinical application to genomic medicine	2
Effects of exercise and nutrition in improving sarcopenia in liver cirrhosis patients: a systematic review and meta-analysis	2
Body mass index and ampulla of Vater cancer incidence and survival: a cohort study of 1.7 million Norwegians	2
Evolving concepts in the management of hepatocellular carcinoma: from ‘stage hierarchy’ to the ‘multiparametric therapeutic hierarchy’ approach	2
Development and internal validation of the Comprehensive ALPPS Preoperative Risk Assessment (CAPRA) score	2
Positive pancreatic neck margins—a telltale sign of complex biology	2
The role of MRI in modifying surgical management of colorectal liver metastases: a lesson from the CAMINO trial	2
Liver transplantation for colorectal liver metastasis: the exception, not the rule	2
Primary Epstein-Barr virus-positive inflammatory follicular dendritic cell sarcoma concurrent with lymphoepithelioma-like intrahepatic cholangiocarcinoma and cavernous hemangioma in liver	2
Long-term normothermic machine perfusion of fatty livers: towards transplanting untransplantable livers?	2
Adjuvant chemotherapy for intrahepatic cholangiocarcinoma: far from a clinical consensus	2
Time-restricted feeding: what we have done and what more we can do?	2
Using the win ratio to compare laparoscopic versus open liver resection for colorectal cancer liver metastases	2
Tract hemostasis using radiofrequency ablation for hepatic arterial bleeding after percutaneous transhepatic portal embolization	2
Patient with unresectable colorectal liver metastases and asymptomatic primary tumor: end of the debate!	2
Role of non-invasive tests in the management of resectable hepatocellular carcinoma: future directions	2
Optimization of outpatient care for patients with decompensated liver cirrhosis: a post-discharge nursing initiative improves quality of life	2
Liver resection, and technical advances to mitigate post-hepatectomy liver failure	2
Utility of liver resection for breast cancer liver metastases, time for action	2
Advancing prognostic models in salvage liver transplantation	2
Giant accessory hepatic lobe accompanied by inflammatory pseudotumor	2
Time to say goodbye: from Barcelona to Milan and the modern management of hepatocellular carcinoma	2
Cystic liver lesions: from diagnosis to recognition of complications and when to treat	2
A European expert consensus surgical technique description for robotic hepatectomy	2
Babylonian clay tablet of the liver	2
Epigenome-wide development and validation of a prognostic methylation score in intrahepatic cholangiocarcinoma based on machine learning strategies	2
Providing meaningful survival benefit to hepatocellular carcinoma patients: combination therapy of future	2
A novel non-invasive model to predict high-risk varices in cirrhotic patients	2
Is FOLFOX-HAIC superior to transarterial chemoembolization in treating large hepatocellular carcinoma?	2
β-cryptoxanthin and fatty liver disease: new insights	2
Predicting early graft loss in pancreas transplantation using novel imaging techniques: are we there yet?	2
A novel nomogram for predicting the prognosis of hepatocellular carcinoma patients following immune checkpoint inhibitors treatment beyond progression: a single center study based on Chinese populatio	2
Primary tumor location and KRAS mutation: key prognostic factors in surgically treated colorectal liver metastases	2
Regional differences: clinical practice guidelines on the management of hepatocellular carcinoma	2
Clinical feasibility of modified extended left hemihepatectomy in advanced perihilar cholangiocarcinoma	2
Foregut bypass vs. restrictive bariatric procedures for nonalcoholic fatty liver disease: a meta-analysis of 3,355 individuals	2
James Hogarth Pringle and his time-honored maneuver	2
Challenges and innovations in adjuvant therapy for gallbladder cancer: a meta-analytic perspective	2
The risk of hepatocellular carcinoma recurrence after liver transplantation increases with locoregional therapies in patients initially within Milan criteria	2
Hypothermic oxygenated machine perfusion for ante-situm liver resection: a note of caution?	2
Hepatocellular carcinoma and intrahepatic cholangiocarcinoma incidence between 2006 and 2015 in China: estimates based on data from 188 population-based cancer registries	2
Anatomical complexity of the right-lobe grafts: influence on the outcomes in living donor liver transplantation	2
Based on the results of a large retrospective study comparing laparoscopic liver surgery and robotic liver surgery, is it time for the next step in robotic liver resection?	2
Robotic-assisted cholecystectomy: stepping stone to expertise or vogue?	2
“PUMC’s Three Treasures”: can their glory remain?	2
Pancreatic exocrine insufficiency guidelines: more questions than answers!	2
Adjuvant therapy for intrahepatic carcinoma after surgical resection: chemotherapy and future perspectives	2
Balancing efficacy and tolerability in metastatic pancreatic cancer: lessons from the ALPACA trial	2
In memoriam of Prof. Joseph Wan-yee Lau—our distinguished senior editorial board member	2
The management strategy of pancreatic cancer in the era of systemic therapy—“Surgery First” or “Surgery Last”?	2
Anatomical study of the paracaval branch of the caudate lobe: implications of paracaval portion-preserving right hepatectomy for donors with marginal remnant liver volume	2
Update on herbal and dietary supplement-induced liver injury: current gaps and future directions	2
Continuous normothermic machine perfusion of donor livers in the United States: the challenging road from the trial-world into the real-world	2
Pancreatic carcinoma disguised as type 1 autoimmune pancreatitis with a mass-forming appearance: a clinical dilemma	2
Hepatectomy guided by the diseased bile duct and hepatic vein for hepatolithiasis	2
A review of 2022 Chinese clinical guidelines on the management of hepatocellular carcinoma: updates and insights	2
Short- and long-term outcomes of laparoscopic versus open resection of perihilar cholangiocarcinoma: a propensity score-based analysis	2
Evaluating liver resection outcomes post Y90 TARE with personalized dosimetry in intermediate or advanced hepatocellular carcinoma: a focus on surgical and biliary complications	2
Phase II trial of hepatic arterial infusion chemotherapy plus bevacizumab and toripalimab for advanced biliary tract cancers: efficacy, safety, and exploratory analysis	2
A combined pre- and intra-operative nomogram in evaluation of degrees of liver cirrhosis predicts post-hepatectomy liver failure: a multicenter prospective study	2
Long-term results of total pancreatectomy and autologous islet transplantation for chronic pancreatitis: total pancreatectomy with autologous islet transplantation (TPAIT) preserves long-term islet gr	2